{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:35:49Z","timestamp":1787726149034,"version":"build-2784847793"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005301","name":"American College of Surgeons","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005301","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ygyno.2019.09.004","type":"journal-article","created":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T08:28:31Z","timestamp":1568104111000},"page":"254-261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Neuroendocrine carcinoma of the endometrium: Disease course, treatment, and outcomes"],"prefix":"10.1016","volume":"155","author":[{"given":"Kathryn","family":"Schlechtweg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caryn M.","family":"St. Clair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana I.","family":"Tergas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fady","family":"Khoury-Collado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June Y.","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Melamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred I.","family":"Neugut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn L.","family":"Hershman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason D.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2019.09.004_bb0005","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/1097-0142(19910701)68:1<98::AID-CNCR2820680120>3.0.CO;2-R","article-title":"Undifferentiated carcinoma of the endometrium. A histopathologic and clinical study of 31 cases","volume":"68","author":"Abeler","year":"1991","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2019.09.004_bb0010","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ygyno.2011.04.011","article-title":"Neuroendocrine tumors of the gynecologic tract: a Society of Gynecologic Oncology clinical document","volume":"122","author":"Gardner","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2019.09.004_bb0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1053\/j.seminoncol.2006.10.028","article-title":"Small cell carcinoma of the female genital tract","volume":"34","author":"Crowder","year":"2007","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ygyno.2019.09.004_bb0020","doi-asserted-by":"crossref","first-page":"450","DOI":"10.4132\/jptm.2015.09.20","article-title":"Neuroendocrine tumors of the female reproductive tract: a literature review","volume":"49","author":"Chun","year":"2015","journal-title":"Journal of Pathology and Translational Medicine"},{"issue":"2","key":"10.1016\/j.ygyno.2019.09.004_bb0025","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ygyno.2014.05.017","article-title":"Small cell carcinoma of the gynecologic tract: a multifaceted spectrum of lesions","volume":"134","author":"Atienza-Amores","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2019.09.004_bb0030","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ctrv.2008.10.007","article-title":"Clinical and therapeutic aspects of extrapulmonary small cell carcinoma","volume":"35","author":"Walenkamp","year":"2009","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"10.1016\/j.ygyno.2019.09.004_bb0035","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/cncr.24858","article-title":"Should extrapulmonary small cell cancer be managed like small cell lung cancer?","volume":"116","author":"Brennan","year":"2010","journal-title":"Cancer"},{"issue":"9804","key":"10.1016\/j.ygyno.2019.09.004_bb0040","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(11)60165-7","article-title":"Small-cell lung cancer","volume":"378","author":"van Meerbeeck","year":"2011","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ygyno.2019.09.004_bb0045","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1053\/j.seminoncol.2006.11.017","article-title":"The pathology of extrapulmonary small cell carcinoma","volume":"34","author":"Frazier","year":"2007","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ygyno.2019.09.004_bb0050","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00004347-199501000-00005","article-title":"Small cell neuroendocrine carcinoma of the endometrium","volume":"14","author":"van Hoeven","year":"1995","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ygyno.2019.09.004_bb0055","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1136\/ijgc-00009577-200409000-00041","article-title":"Small cell carcinoma of the endometrium: report of three cases and literature review","volume":"14","author":"Katahira","year":"2004","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2019.09.004_bb0060","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/00000478-199404000-00005","article-title":"Small cell carcinoma of the endometrium. A clinicopathological study of sixteen cases","volume":"18","author":"Huntsman","year":"1994","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.ygyno.2019.09.004_bb0065","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/PAS.0000000000000633","article-title":"Neuroendocrine carcinoma of the endometrium: a clinicopathologic study of 25 cases","volume":"40","author":"Pocrnich","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ygyno.2019.09.004_bb0070","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.tjog.2013.05.006","article-title":"Small cell neuroendocrine carcinoma of the endometrium: a clinicopathologic study of six cases","volume":"53","author":"Koo","year":"2014","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2019.09.004_bb0075","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/pgp.0b013e31806219c5","article-title":"Combined large cell neuroendocrine and endometrioid carcinoma of the endometrium","volume":"27","author":"Mulvany","year":"2008","journal-title":"Int J Gynecol Pathol"},{"issue":"3","key":"10.1016\/j.ygyno.2019.09.004_bb0080","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/PGP.0b013e31815de006","article-title":"Small cell carcinomas and large cell neuroendocrine carcinomas of the endometrium and cervix: polypoid tumors and those arising in polyps may have a favorable prognosis","volume":"27","author":"Albores-Saavedra","year":"2008","journal-title":"Int J Gynecol Pathol"},{"issue":"4","key":"10.1016\/j.ygyno.2019.09.004_bb0085","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/1097-0142(19820815)50:4<760::AID-CNCR2820500423>3.0.CO;2-H","article-title":"Small-cell carcinoma of the endometrium light microscopic and ultrastructural study of a case","volume":"50","author":"Olson","year":"1982","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2019.09.004_bb0090","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/jog.12881","article-title":"Combined large-cell neuroendocrine carcinoma and endometrioid adenocarcinoma of the endometrium: a case report and survery of related literature","volume":"42","author":"Matsumoto","year":"2016","journal-title":"J\u00a0Obstet Gynaecol Res"},{"issue":"28","key":"10.1016\/j.ygyno.2019.09.004_bb0095","first-page":"45323","article-title":"A\u00a0Clinical analysis of small-cell neuroendocrine carcinoma of the gynecologic tract: report of 20 cases","volume":"8","author":"He","year":"2018","journal-title":"Arch Gynecol Obstet"},{"issue":"28","key":"10.1016\/j.ygyno.2019.09.004_bb0100","doi-asserted-by":"crossref","first-page":"45323","DOI":"10.18632\/oncotarget.17335","article-title":"PI3K inhibitor enhances the cytotoxic response to etoposide and cisplatin in a newly established neuroendocrine cervical carcinoma cell line","volume":"8","author":"Lai","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ygyno.2019.09.004_bb0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40661-017-0038-9","article-title":"Metastatic small cell neuroendocrine carcinoma of the cervix treated with the PD-1 inhibitor, nivolumab: a case report","volume":"4","author":"Paraghamian","year":"2017","journal-title":"Gynecol Oncol Res Pract"},{"key":"10.1016\/j.ygyno.2019.09.004_bb0110","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.gore.2014.09.003","article-title":"Response to MEK inhibitor in small cell neuroendocrine carcinoma of the cervix with a KRAS mutation","volume":"10","author":"Lyons","year":"2014","journal-title":"Gynecol Oncol Rep"},{"key":"10.1016\/j.ygyno.2019.09.004_bb0120","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1245\/s10434-007-9747-3","article-title":"The National Cancer Data Base: a powerful initiative to improve cancer care in the United States","volume":"15","author":"Bilimoria","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ygyno.2019.09.004_bb0125","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1200\/JCO.2013.51.4109","article-title":"Southwest Oncology Group S0802: a randomized-phase II trial of weekly topotecan with and without ziv-aflibercept in patients with platinum-treated small-cell lung cancer","volume":"32","author":"Allen","year":"2014","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.ygyno.2019.09.004_bb0130","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1158\/2159-8290.CD-12-0112","article-title":"Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1","volume":"2","author":"Byers","year":"2012","journal-title":"Cancer Discovery"},{"key":"10.1016\/j.ygyno.2019.09.004_bb0135","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1200\/JCO.2010.29.3423","article-title":"Randomized phase II study of bevacizumab in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancer: results from the SALUTE trial","volume":"29","author":"Spigel","year":"2011","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.ygyno.2019.09.004_bb0140","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1056\/NEJMoa1309748","article-title":"Improved survival with bevacizumab in advanced cervical cancer","volume":"370","author":"Tewari","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ygyno.2019.09.004_bb0145","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.critrevonc.2014.03.003","article-title":"Treatment of small cell lung cancer","volume":"91","author":"Morabito","year":"2014","journal-title":"Critical Reviews in Oncology\/Hematology"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825819315227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825819315227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:45:35Z","timestamp":1758771935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825819315227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0090825819315227"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2019.09.004","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroendocrine carcinoma of the endometrium: Disease course, treatment, and outcomes","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2019.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}